DB15180InvestigationalGene Therapies
Cystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).
Resolves to
Compound
What you can answer from here — as of September 25, 2025
Which companies are running trials of Cystic fibrosis transmembrane conductance regulator, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account